纵向数据中亚组处理效应的统一分析框架
本文提出一种半参数亚组变系数模型,可直接从纵向数据中同时估计亚组数量与亚组特异性处理效应,无需预设亚组数或相关结构。通过惩罚EM算法实现亚组识别与效应估计,并建立估计量的一致性与渐近正态性。模拟实验及两项真实数据集应用显示,该方法能识别有意义的患者亚组并揭示亚组特异性、时变的治疗敏感性。
要点
- 新方法可同时估计亚组数量与亚组特异性处理效应。
- 惩罚EM算法实现亚组识别与效应估计一体化。
- 在癫痫药物试验和原发性胆汁性肝硬化试验中验证有效。
核心结论
- 所提出的半参数亚组变系数模型能直接从纵向数据中同时估计亚组数量与亚组特异性处理效应。
- 模拟实验和两个真实数据集应用表明该方法能识别有意义的患者亚组并揭示亚组特异性、时变的治疗敏感性。
研究设计与样本
- 方法学研究,提出半参数亚组变系数模型并开发惩罚EM算法。
- 通过广泛模拟实验评估方法效能与稳健性。
- 应用于标准与新型抗癫痫药物研究及Mayo Clinic原发性胆汁性肝硬化试验两个真实纵向数据集。
主要发现
- 模拟实验表明该方法在识别亚组和估计处理效应方面具有良好效能与稳健性。
- 在抗癫痫药物研究中成功识别有意义的患者亚组并揭示亚组特异性、时变的治疗敏感性。
- 在原发性胆汁性肝硬化试验中同样成功识别亚组并揭示亚组特异性、时变的治疗敏感性。
临床怎么用
- 为纵向数据中探索亚组特异性、时变处理效应提供无需预设亚组数或相关结构的统一分析框架。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The rise of precision medicine has shifted statistical analysis from population-averaged treatment effects to subgroup-specific effects, highlighting the importance of tailoring treatments to distinct patient subgroups. Longitudinal data, in particular, provides an opportunity to study how treatment effects evolve over time. However, methods for analyzing subgroup-specific, time-varying treatment effects in longitudinal settings remain limited. Most current approaches rely on two-step procedures with restrictive assumptions, such as a fixed number of subgroups or prespecified correlation structures. In this paper, we propose a novel semiparametric subgroup-varying-coefficient model that simultaneously estimates all unknowns, including the number of subgroups and subgroup-specific treatment effects, directly from longitudinal data without requiring restrictive assumptions. We develop a penalized Expectation-Maximization (EM) algorithm that simultaneously identifies the subpopulations and estimates the treatment effects in different subgroups. We establish the theoretical properties of the proposed estimators, including consistency and asymptotic normality. The efficacy and robustness of the method are demonstrated through extensive simulations and applications to two real-world datasets: the Standard and New Antiepileptic Drugs study and the Mayo Clinic trial on primary biliary cirrhosis. In both cases, our approach successfully identifies meaningful patient subgroups and reveals subgroup-specific, time-varying treatment sensitivities.
引用
- Zhang P, Zhang X, Jin J, et al. Varying Treatment Effects in Subgroups: A Unified Framework for Longitudinal Data Analysis. Stat Med. 2026. PMID: 42144824. doi:10.1002/sim.70600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。